Ayr Wellness Operating Margin 2020-2024 | AYRWF
Current and historical operating margin for Ayr Wellness (AYRWF) over the last 10 years. The current operating profit margin for Ayr Wellness as of December 31, 2024 is -35.41%.
| Ayr Wellness Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.46B | $-0.16B | -34.77% |
| 2024-09-30 | $0.46B | $-0.04B | -7.76% |
| 2024-06-30 | $0.46B | $-0.02B | -4.31% |
| 2024-03-31 | $0.46B | $-0.02B | -3.66% |
| 2023-12-31 | $0.46B | $-0.04B | -7.97% |
| 2023-09-30 | $0.46B | $-0.17B | -36.93% |
| 2023-06-30 | $0.46B | $-0.19B | -41.27% |
| 2023-03-31 | $0.44B | $-0.21B | -47.27% |
| 2022-12-31 | $0.42B | $-0.21B | -49.05% |
| 2022-09-30 | $0.42B | $-0.08B | -18.57% |
| 2022-06-30 | $0.41B | $-0.07B | -16.71% |
| 2022-03-31 | $0.40B | $-0.07B | -17.29% |
| 2021-12-31 | $0.36B | $-0.06B | -15.69% |
| 2021-09-30 | $0.29B | $-0.04B | -11.95% |
| 2021-06-30 | $0.24B | $-0.02B | -7.02% |
| 2021-03-31 | $0.18B | $0.00B | 1.68% |
| 2020-12-31 | $0.16B | $0.00B | 1.29% |
| 2020-09-30 | $0.14B | $-0.02B | -15.83% |
| 2020-06-30 | $0.13B | $-0.04B | -33.33% |
| 2020-03-31 | $0.11B | $-0.05B | -41.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.004B | $0.464B |
| Ayr Wellness Inc. is a vertically integrated, multi-state cannabis operator, focused on delivering cannabis products and customer experience. Ayr Wellness Inc., formerly known as AYR WIRELESS, is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
| Boston Scientific (BSX) | United States | $157.644B | 37.59 |
| Stryker (SYK) | United States | $150.755B | 30.69 |
| EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
| Medtronic (MDT) | Ireland | $118.256B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
| ResMed (RMD) | United States | $41.753B | 29.86 |
| GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
| Agilent Technologies (A) | United States | $33.605B | 21.91 |
| Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
| Terumo (TRUMY) | Japan | $26.532B | 31.44 |
| Insulet (PODD) | United States | $23.358B | 78.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.337B | 0.00 |
| Baxter (BAX) | United States | $12.584B | 9.72 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
| Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
| Envista Holdings (NVST) | United States | $3.513B | 24.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
| ICU Medical (ICUI) | United States | $3.109B | 21.17 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| Acuren (TIC) | United States | $2.156B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.223B | 19.41 |
| Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.941B | 8.70 |
| Valneva SE (VALN) | France | $0.762B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.683B | 0.00 |
| SNDL (SNDL) | Canada | $0.649B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Surmodics (SRDX) | United States | $0.496B | 0.00 |
| Evolus (EOLS) | United States | $0.495B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
| CeriBell (CBLL) | United States | $0.420B | 0.00 |
| Owens & Minor (OMI) | United States | $0.387B | 3.43 |
| Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.301B | 61.15 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
| Omeros (OMER) | United States | $0.298B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Quanterix (QTRX) | United States | $0.218B | 0.00 |
| Exagen (XGN) | United States | $0.218B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
| Biote (BTMD) | United States | $0.164B | 5.43 |
| Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.32 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 32.90 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.67 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.62 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |